Evaluation of Intra-operative Photographs for the Assessment of a Proper Lymphadenectomy in Minimally-invasive Gastrectomies for Gastric Cancer (PhotoNodes)
NCT06466902 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 326
Last updated 2024-07-05
Summary
Even after the wide introduction of chemo/radiotherapy in the treatment algorithm, adequate surgery remains the cornerstone of gastric cancer treatment with curative intent. A proper D2 lymphadenectomy is associated with improved cancer specific survival as confirmed in Western countries by fifteen-year follow-up results of Dutch and Italian randomized trials.
In clinical practice, the total number of harvested lymph nodes is often considered as a surrogate marker for adequate D2 lymphadenectomy; nonetheless, the number of retrieved nodes does not necessarily correlate with residual nodes, which intuitively could represent a more reliable marker of surgical adequacy. The availability of an efficient tool for evaluating the absence of residual nodes in the operative field at the end of node dissection could better correlate with survival outcomes.
The goal of this multicentric observational prospective study is to test the reliability of a new score (PhotoNodes Score) created to rate the quality of the lymphadenectomy performed during minimally invasive gastrectomy for gastric cancer. The score is assigned by assessing the absence of residual nodes at the end of node dissection on a set of laparoscopic/robotic high quality intraoperative images collected from each patient undergoing a minimally invasive gastrectomy with D2 node dissection.
Ideally, this tool could be a new indicator of the quality of D2 dissection and could assume a prognostic role in the treatment of gastric cancer.
Conditions
- Gastric Cancer
- Gastric Adenocarcinoma
- Lymphadenectomy
- Minimally Invasive Surgery
- Gastrectomy for Gastric Cancer
- Laparoscopic Surgery
- Robotic Surgery
- Survival Outcomes
- Survival Analysis
- Quality Of Care
Interventions
- OTHER
-
Quality assessment of D2 lymphadenectomy using the PhotoNode Score
During the surgical procedure, a set of 5 high quality laparoscopic intraoperative images of the surgical field will be put on record. Photographs will be taken at the end of the lymphadenectomy phase, before the reconstructive phase begins. Three surgeons will review the images. Quality of D2 lymphadenectomy will be assessed independently rating eight node stations (1, 5, 6, 7, 8a, 9, 11p and 12a), based upon the evaluation of the 5 images. Each node station will be given a score from 0 to 3, corresponding to a judgment of Unevaluable (0), Poor (1), Doubtful (2) or Excellent (3) lymphadenectomy respectively, in that specific node station. A total score for each patient will be independently obtained from each reviewer ranging from a minimum of 7 (poor lymphadenectomy) to a maximum of 24 (excellent lymphadenectomy). The PNS for each patient will originate from the average score among the three reviewers.
Sponsors & Collaborators
-
Azienda Ospedaliero-Universitaria di Parma
lead OTHER
Principal Investigators
-
Giorgio Dalmonte, MD, PhD · Azienda Ospedaliero-Universitaria di Parma
-
Federico Marchesi, Prof. · Azienda Ospedaliero-Universitaria di Parma
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-22
- Primary Completion
- 2024-12-31
- Completion
- 2027-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Laparoscopic-assisted Total Gastrectomy Versus Open Total Gastrectomy With Splenic Hilum Lymph Nodes Dissection
NCT02711033 ·Status: UNKNOWN ·Phase: PHASE2
-
Factors Affecting the Difficulty of Laparoscopic D2 Lymph Node Dissection for Gastric Cancer
NCT05585073 ·Status: COMPLETED
-
Study on Laparoscopic D2 Lymphadenectomy Plus Complete Mesogastrium Excision(D2+CME)for Advanced Gastric Cancer
NCT01978444 ·Status: UNKNOWN ·Phase: NA
-
Randomized Controlled Trials on Laparoscopic No. 14v LNS Dissection
NCT02789891 ·Status: UNKNOWN ·Phase: NA
-
Long-term Oncologic Outcomes of Robotic Versus Laparoscopic Total Gastrectomy for Advanced Gastric Cancer
NCT05181306 ·Status: COMPLETED
-
D1 Versus D2 Lymphadenectomy in High Risk Elderly With Gastric Adenocarcinoma
NCT03051152 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Middle or Upper Third Gastric Cancer
NCT02333721 ·Status: UNKNOWN ·Phase: NA
-
Curative D2 vs D1 Lymphadenectomy in Operable Gastric Carcinoma
NCT04340440 ·Status: COMPLETED ·Phase: NA
-
Effect of Lymph Node Ratio in Gastric Cancer to Determine Recurrence Rate After Curative Resection
NCT03778710 ·Status: COMPLETED
-
Multicenter Study on Laparoscopic Distal Subtotal Gastrectomy for Advanced Gastric Cancer (CLASS-01)
NCT01609309 ·Status: UNKNOWN ·Phase: PHASE3
-
A Multicenter Clinical Trial on Laparoscopic Gastric Cancer Surgery Compared With Open Surgery
NCT02302794 ·Status: UNKNOWN ·Phase: PHASE3
-
Analysis of Lymph Node Metastasis and Tumor Deposit in the Short Gastric Mesentery Following Total Gastrectomy for Gastric Cancer
NCT06728878 ·Status: RECRUITING
-
Exploration of Lymph Node Metastasis and Tumor Deposit in the Posterior Gastric Mesentery for Distal Gastric Cancer
NCT06736847 ·Status: RECRUITING
-
The Safety, Feasibility and Oncological Outcomes of Laparoscopic Completion Total Gastrectomy for Remnant Gastric Cancer
NCT02792881 ·Status: UNKNOWN ·Phase: NA
-
Prospective Phase II Trial on Prophylactic Perihepatic Lymphadenectomy in Patients With Colorectal Cancer With Liver Metastasis
NCT01565811 ·Status: COMPLETED
-
Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for AGC
NCT03708783 ·Status: UNKNOWN ·Phase: NA
-
CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma
NCT04727242 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Short-term Outcomes of Laparoscopic Versus Open Gastrectomy With Lymph Node Dissection for Early Gastric Cancer :a Randomized Controlled Study
NCT05707338 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of PET and Laparoscopy in STagIng Advanced Gastric Cancer
NCT03208621 ·Status: UNKNOWN
-
Postoperative Morbidity and Mortality After Gastrectomy for Gastric Cancer: Prospective Cohort Study
NCT01919242 ·Status: UNKNOWN
-
Dissecting the Pattern of Nodal Spread in Post-neoadjuvant Pancreatoduodenectomy
NCT06135649 ·Status: RECRUITING
-
Effectiveness of Managing Suspected Metastasis and Progress Using Plasma D-dimer Testing in Gastric Cancer Patients
NCT04953585 ·Status: COMPLETED
-
The Clinical Significance of Examining Metastatic Lymph Nodes in Individual Gastric Mesenteries in the Patients With Gastric Cancer Undergoing Gastrectomy
NCT07139418 ·Status: RECRUITING
-
A Trial to Evaluate the Superior Mesenteric Vein (14V) Lymphadenectomy for Distal Advanced Gastric Cancer
NCT02272894 ·Status: UNKNOWN
-
D1 vs D2 Lymphadenectomy in Gastric Cancer
NCT05253430 ·Status: COMPLETED